Small Business Teaming / Prime Substitution for Future Orders

This contract opportunity is designed to enable certified small or disadvantaged pharmaceutical suppliers to collaborate with or supply through a prime contractor for future indefinite-delivery, indefinite-quantity (IDIQ) orders under the same contract vehicle. The initiative aims to enhance participation from small and disadvantaged businesses in the pharmaceutical supply chain supporting the Department of Defense by allowing them to form teaming arrangements or act as substitutes to the prime without requiring a separate contract award. The North American Industry Classification System code 325412 indicates the focus is on pharmaceutical and biological product manufacturing, ensuring alignment with the Defense Logistics Agency’s needs in this critical sector. The opportunity is open to eligible firms interested in supporting future delivery orders under contract SPE2DX25D9822, with performance expected to align with Department of Defense requirements though specific locations have not been designated. The contract was posted in mid-2026, signaling a forward-looking procurement strategy to expand small business engagement in defense pharmaceutical procurement.